Toll-like receptor agonist mouthwash for preventing and treating oral ulcer
A technology of receptor agonist and oral ulcer, which is applied in the field of oral care, can solve the problems of high timeliness, easy recurrence, and large side effects, and achieve the effect of strong functionality, short treatment time, and quick onset
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] A Toll-like receptor agonist mouthwash for preventing and treating oral ulcers, the weight percentage of its raw materials is: Pam3CSK4 1.51×10 -8 %, polyinosinic acid 1.0%, imiquimod 2.76×10 -10 %, CpG-ODN 1.4×10 -7 %, 0.05% chlorhexidine acetate, 0.3% cyclamate, 7.0% moisturizing agent, 2.0% peppermint essential oil, 0.03% zinc citrate, 0.06% thymol, and the balance is distilled water; the moisturizing agent is a mixture of sorbitol and glycerin Mixture, the mixing weight ratio is 5:1.
[0025] Among them, the preparation method is to mix the raw materials according to the corresponding weight ratio, stir fully to dissolve evenly, pour into the pasteurization instant sterilizer, heat to 95°C, and maintain it for 20 seconds to complete the sterilization. The solution should be quickly packed into a sterilized glass bottle and sealed while hot, so as to obtain the Toll-like receptor agonist mouthwash for preventing and treating oral ulcers.
Embodiment 2
[0027] A Toll-like receptor agonist mouthwash for preventing and treating oral ulcers, the weight percentage of its raw materials is: Pam3CSK4 1.51×10 -8 %, polyinosinic acid 3.0%, imiquimod 2.76×10 -10 %, CpG-ODN 1.4×10 -7 %, 0.03% chlorhexidine acetate, 0.4% cyclamate, 6.0% humectant, 1.0% peppermint essential oil, 0.04% zinc citrate, 0.08% thymol, and the balance is distilled water; all the other contents are the same as in Example 1.
Embodiment 3
[0029] A Toll-like receptor agonist mouthwash for preventing and treating oral ulcers, the weight percentage of its raw materials is: Pam3CSK4 1.51×10 -8 %, polyinosinic acid 1.0%, imiquimod 2.76×10 -10 %, CpG-ODN 1.4×10 -7 %, 0.01% chlorhexidine acetate, 0.2% cyclamate, 6.0% humectant, 2.0% peppermint essential oil, 0.03% zinc citrate, 0.04% thymol, and the balance is distilled water; all the other contents are the same as in Example 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com